Everence Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$968K Hold
2,970
0.06% 235
2025
Q1
$802K Buy
2,970
+450
+18% +$122K 0.05% 269
2024
Q4
$593K Buy
+2,520
New +$593K 0.04% 317